felin
infecti
periton
fip
consid
fatal
diseas
three
cat
dri
form
fip
treat
polyprenyl
immunostimul
two
three
cat
still
treatment
aliv
well
year
diagnosi
third
cat
surviv
month
treat
month
studi
necessari
assess
potenti
polyprenyl
immunostimul
f
elin
infecti
periton
fip
devast
diseas
seen
frequent
young
cat
due
mutat
form
felin
coronaviru
induc
pyogranulomat
perivascular
reaction
seros
surfac
abdomen
thorax
larg
amount
exud
produc
lesion
result
wet
form
fip
dri
noneffus
form
character
pyogranulomat
infiltr
lymph
node
kidney
liver
eye
brain
produc
inflammatori
mass
organ
dri
form
consid
less
aggress
form
diseas
immun
control
inflammatori
process
fip
long
consid
incur
diseas
report
longterm
control
nonplacebo
control
studi
done
dr
ishida
use
glucocorticoid
recombin
felin
interferonomega
treatment
produc
remiss
cat
fip
placebo
control
doubl
blind
studi
cat
mainli
effus
form
fip
treat
steroid
amoxicillinclavulan
acid
recombin
felin
interferonomega
differ
placebo
group
group
treat
recombin
felin
interferon
median
surviv
time
cat
day
longest
surviv
cat
live
day
cat
surviv
day
treatment
group
felin
interferon
avail
unit
state
object
studi
assess
effect
polyprenyl
immunostimul
surviv
time
cat
dri
form
fip
polyprenyl
immunostimul
investig
veterinari
biolog
manufactur
sass
sass
inc
compris
mixtur
phosphoryl
linear
polyisoprenol
agent
low
toxic
oral
absorb
substanc
shown
upregul
biosynthesi
mrna
cytokin
use
treatment
number
viral
diseas
substanc
administ
cat
concentr
mgml
administr
rout
frequenc
describ
case
studi
cat
consid
elig
initi
studi
histologichistopatholog
evid
lesion
compat
fip
adequ
support
test
coronaviru
antibodi
titer
polyclon
gammopathi
requir
well
test
exclud
diseas
process
kg
femal
domest
shorthair
cat
multipl
cat
household
brought
univers
tennesse
veterinari
teach
hospit
juli
abdomin
mass
found
ovariohysterectomi
ohe
mass
bled
easili
touch
ohe
abort
cat
less
activ
normal
sever
month
largest
abdomin
mass
approxim
cm
examin
veterinari
teach
hospit
cat
depress
respons
cat
hematocrit
normal
rang
neutrophilia
cellsml
normal
rang
lymphopenia
cell
ml
normal
cat
neg
felin
leukemia
viru
coronaviru
antibodi
titer
signific
chang
plasma
chemistri
panel
hyperglobulinemia
gdl
normal
hypoalbuminemia
gdl
normal
total
bilirubin
mgdl
normal
abdomin
ultrasonographi
local
mass
area
mesenter
lymph
node
mass
incorpor
sever
loop
small
intestin
cytolog
obtain
needl
aspir
mass
design
granulomat
lymphaden
clinic
diagnosi
fip
made
poor
prognosi
given
owner
cat
start
treatment
august
dose
mgkg
twice
day
polyprenyl
immunostimul
dilut
ml
salin
given
subcutan
next
month
cat
improv
eat
well
bodi
weight
increas
kg
abdomin
mass
unchang
assess
abdomin
palpat
coronaviru
antibodi
titer
drop
less
globulin
level
continu
increas
reach
gdl
cat
spay
mass
biopsi
biopsi
assess
mark
pyogranulamat
inflamm
highli
suggest
fip
cat
continu
polyprenyl
immunostimul
anoth
month
well
treatment
discontinu
famili
problem
preclud
return
cat
univers
tennesse
reevalu
cat
return
reevalu
month
initi
evalu
polyprenyl
immunostimul
month
cat
start
get
atax
month
reevalu
cat
lost
kg
last
month
diarrhea
polyprenyl
immunostimul
restart
week
reevalu
improv
note
euthanasia
perform
necropsi
ml
clear
fluid
abdomen
small
intestin
markedli
thicken
sever
lymphoplasmacyt
infiltr
lesser
number
macrophag
neutrophil
similar
infiltr
found
mening
final
diagnosi
fip
cat
surviv
month
start
treatment
kg
malecastr
domest
shorthair
cat
seen
april
kg
weight
loss
previou
week
cat
scruffi
appear
cm
diamet
midabdomin
mass
palpat
cat
increas
plasma
protein
gdl
normal
rang
albumin
gdl
normal
plasma
globulin
concentr
gdl
normal
initi
coronaviru
antibodi
titer
exploratori
surgeri
may
identifi
mass
greatli
enlarg
mesenter
lymph
node
mass
character
sever
chronicact
pyogranulomat
necrot
lymphaden
pathologist
comment
chang
fairli
typic
fip
viru
infect
special
stain
bacteri
cultur
identifi
fungal
mycobacteri
bacteri
infect
tissu
posit
coronaviru
antigen
immunohistochemistri
clinic
diagnosi
fip
made
cat
treat
polyprenyl
immunostimul
dose
mgkg
given
oral
twice
week
start
june
start
therapi
repeat
serum
coronaviru
antibodi
titer
posit
serum
protein
electrophoresi
broad
base
polyclon
gammopathi
gdl
normal
increas
globulin
gdl
normal
reexamin
month
start
polyprenyl
immunostimul
treatment
mass
smaller
approxim
cm
diamet
gammaglobulin
concentr
decreas
normal
level
gdl
globulin
gdl
cat
continu
polyprenyl
immunostimul
februari
cat
clinic
normal
plasma
globulin
concentr
normal
g
dl
coronaviru
antibodi
titer
posit
cat
continu
polyprenyl
immunostimul
treatment
last
convers
cat
veterinarian
juli
cat
appear
normal
well
malecastr
kg
abyssinian
cat
seen
februari
routin
evalu
consid
blood
donor
cat
neutrophilia
cellsml
normal
rang
cellsml
hyperproteinemia
gdl
normal
globulin
gdl
normal
hypoalbuminemia
gdl
normal
midabdomin
mass
palpat
identifi
radiograph
ultrasonograph
imag
involv
midabdomin
lymph
node
mass
longest
diamet
cytolog
aspir
mass
indic
suppur
pyogranulomat
lymphaden
eye
normal
cat
start
azithromycin
day
await
result
pend
test
cat
felin
leukemia
viru
antigen
enzymelink
immunosorb
assay
elisa
test
felin
immunodefici
viru
antibodi
titer
neg
increas
globulin
due
polyclon
gammopathi
concurr
increas
globulin
serum
coronaviru
antibodi
titer
greater
clinic
diagnosi
dri
form
fip
made
februari
cat
start
polyprenyl
immunostimul
given
oral
dose
mgkg
twice
week
frequenc
increas
three
time
week
june
mass
bigger
palpat
gammaglobulin
concentr
increas
gdl
normal
coronaviru
antibodi
titer
remain
greater
globulin
concentr
slowli
steadili
increas
electrophoresi
done
januari
gammaglobulin
concentr
gdl
march
cat
episod
retinopathi
uveiti
consist
fip
eye
chang
respond
topic
steroid
therapi
cat
clinic
normal
june
month
sinc
initi
diagnosi
start
polyprenyl
immunostimul
spite
persist
neutrophilia
hypergammaglobulinemia
coronaviru
antibodi
titer
gener
accept
fip
fatal
diseas
review
articl
treatment
cat
fip
state
current
effect
therapeut
regim
control
fip
treatment
affect
expect
cours
diseas
process
initi
consider
incorrect
diagnosi
made
believ
clinic
find
three
cat
strongli
support
diagnosi
fip
make
definit
diagnosi
dri
form
fip
difficult
diagnost
workup
three
cat
somewhat
differ
cytolog
histolog
find
consist
fip
found
cat
initi
diagnost
period
cat
treat
polyprenyl
immunostimul
pyogranulomat
diseas
present
sign
condit
appear
year
treatment
polyclon
gammopathi
note
three
cat
cat
diagnosi
confirm
necropsi
lymph
node
biopsi
assess
fip
cat
histolog
chang
consist
fip
coronaviru
antigen
found
granulomat
lesion
cat
pyogranulomat
lymphaden
persist
increas
coronaviru
antibodi
titer
polyclon
gammopathi
strongli
support
diagnosi
fip
demonstr
coronaviru
antigen
cytolog
would
enhanc
certainti
diagnosi
cat
toler
treatment
well
advers
effect
attribut
polyprenyl
immunostimul
experiment
model
dri
form
fip
therefor
studi
must
undertaken
natur
occur
diseas
experi
treatment
wet
form
fip
polyprenyl
immunostimul
dismal
probabl
rapid
progress
diseas
process
allow
time
immun
respons
modifi
cours
diseas
surviv
time
cat
fip
gener
short
studi
interferonomega
treatment
fip
median
surviv
time
day
longest
surviv
cat
live
day
cat
studi
effus
form
fip
difficult
predict
surviv
time
cat
dri
form
fip
addi
jarett
state
cat
noneffus
fip
surviv
mani
week
month
surviv
time
studi
cat
longer
would
expect
experi
veterinari
literatur
placebo
control
group
polyprenyl
immunostimul
appear
control
diseas
process
cat
dri
form
fip
studi
need
assess
treatment
current
polyprenyl
immunostimul
investig
veterinari
biolog
commerci
avail
obtain
contact
dr
al
legendr
alegendr
utkedu
manufactur
sass
sass
inc
info
sassandsasscom
cat
well
document
dri
form
fip
consid
inclus
subsequ
studi
